Healthcare Realty Trust (NYSE:HR) Releases FY25 Earnings Guidance

Healthcare Realty Trust (NYSE:HR) issued an update on its FY25 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $1.56 to $1.60 for the period, compared to the consensus estimate of $1.59. Healthcare Realty Trust also updated its FY 2025 guidance to 1.560-1.600 EPS.

Healthcare Realty Trust Stock Down 1.3 %

NYSE:HR traded down $0.22 during mid-day trading on Thursday, hitting $16.56. 433,887 shares of the stock traded hands, compared to its average volume of 2,340,432. The business’s 50-day moving average price is $16.68 and its 200 day moving average price is $17.42. The company has a market cap of $5.87 billion, a PE ratio of -10.47 and a beta of 0.94. Healthcare Realty Trust has a 12-month low of $12.77 and a 12-month high of $18.90.

Healthcare Realty Trust (NYSE:HR) last issued its quarterly earnings data on Wednesday, February 19th. The real estate investment trust reported $0.40 EPS for the quarter, beating the consensus estimate of $0.39 by $0.01. The company had revenue of $309.77 million during the quarter, compared to analysts’ expectations of $303.81 million. Healthcare Realty Trust had a negative net margin of 45.63% and a negative return on equity of 9.42%. Healthcare Realty Trust’s revenue for the quarter was down 6.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.39 earnings per share. Analysts anticipate that Healthcare Realty Trust will post 1.55 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

HR has been the subject of a number of recent research reports. JPMorgan Chase & Co. lowered shares of Healthcare Realty Trust from an “overweight” rating to a “neutral” rating and set a $19.00 price objective for the company. in a report on Friday, December 20th. Wedbush lowered shares of Healthcare Realty Trust from a “neutral” rating to an “underperform” rating and lowered their price target for the company from $18.00 to $16.00 in a report on Thursday, January 2nd. Finally, Jefferies Financial Group lowered shares of Healthcare Realty Trust from a “buy” rating to a “hold” rating and lowered their price target for the company from $19.00 to $17.00 in a report on Thursday, January 2nd. Two investment analysts have rated the stock with a sell rating and four have assigned a hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $17.00.

Insider Transactions at Healthcare Realty Trust

In related news, COO Robert E. Hull sold 10,000 shares of the stock in a transaction that occurred on Tuesday, December 17th. The shares were sold at an average price of $17.48, for a total value of $174,800.00. Following the completion of the sale, the chief operating officer now directly owns 171,400 shares of the company’s stock, valued at approximately $2,996,072. This represents a 5.51 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Thomas N. Bohjalian bought 7,750 shares of Healthcare Realty Trust stock in a transaction that occurred on Friday, November 22nd. The stock was purchased at an average cost of $17.39 per share, with a total value of $134,772.50. Following the completion of the acquisition, the director now directly owns 50,002 shares in the company, valued at $869,534.78. This represents a 18.34 % increase in their position. The disclosure for this purchase can be found here. Insiders have acquired 18,750 shares of company stock worth $323,723 in the last quarter. Company insiders own 0.56% of the company’s stock.

About Healthcare Realty Trust

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.